Given the emerging role of Sdc1 as an organizer of matrix- and growth factor-dependent signaling, we speculated that the tumor-promoting activity of HPSE may trace to its activation of such a mechanism during myeloma cell adhesion and invasion. The gene discussed is SDC1; the disease is plasma cell myeloma.